EagleBridge Capital, working exclusively on behalf of its client, has arranged permanent mortgage financing in the amount of $4.75 million for 255 and 261 Ballardvale Ave.
The mortgage financing was arranged by EagleBridge principals Ted Sidel and Brian Sheehan who stated that the loan was provided by a leading financial institution.
Both buildings are net leased to Charles River Laboratories, Inc. 255 Ballardvale Ave. is a 25,000 s/f office building. 261 Ballardvale is a 60,000 s/f R&D services facility which was fully renovated in 2012. It expands Charles River's diagnostic capabilities for research model health monitoring, clinical chemistry, hematology, biomarker assay development, and immunoassay services.
EagleBridge Capital is a Boston-based mortgage banking firm.
specializing in arranging debt and equity financing as well as joint ventures for industrial, office, and r & d buildings, shopping centers, apartments, hotels, condominiums and mixed use properties as well as special purpose buildings.
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies, and leading academic institutions around the globe accelerate their research and drug development efforts. Founded in 1947, it has grown to become one of the largest global preclinical contract research organizations with approximately 1,000 employees in Massachusetts, and 7,100 employees globally.